These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11134507)

  • 41. alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.
    Taga T; Suzuki A; Gonzalez-Gomez I; Gilles FH; Stins M; Shimada H; Barsky L; Weinberg KI; Laug WE
    Int J Cancer; 2002 Apr; 98(5):690-7. PubMed ID: 11920637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion.
    Björklund M; Heikkilä P; Koivunen E
    J Biol Chem; 2004 Jul; 279(28):29589-97. PubMed ID: 15123665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
    Kang IC; Kim DS; Jang Y; Chung KH
    Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
    Felding-Habermann B; Fransvea E; O'Toole TE; Manzuk L; Faha B; Hensler M
    Clin Exp Metastasis; 2002; 19(5):427-36. PubMed ID: 12198771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
    Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
    Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
    Meerovitch K; Bergeron F; Leblond L; Grouix B; Poirier C; Bubenik M; Chan L; Gourdeau H; Bowlin T; Attardo G
    Vascul Pharmacol; 2003 Feb; 40(2):77-89. PubMed ID: 12646396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
    Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
    Petitclerc E; Strömblad S; von Schalscha TL; Mitjans F; Piulats J; Montgomery AM; Cheresh DA; Brooks PC
    Cancer Res; 1999 Jun; 59(11):2724-30. PubMed ID: 10363998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
    Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
    Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.
    Voura EB; Ramjeesingh RA; Montgomery AM; Siu CH
    Mol Biol Cell; 2001 Sep; 12(9):2699-710. PubMed ID: 11553709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature.
    Cao L; Du P; Jiang SH; Jin GH; Huang QL; Hua ZC
    Mol Cancer Ther; 2008 Apr; 7(4):851-61. PubMed ID: 18413798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction.
    Gawaz M; Neumann FJ; Dickfeld T; Reininger A; Adelsberger H; Gebhardt A; Schömig A
    Circulation; 1997 Sep; 96(6):1809-18. PubMed ID: 9323066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.
    Bello L; Francolini M; Marthyn P; Zhang J; Carroll RS; Nikas DC; Strasser JF; Villani R; Cheresh DA; Black PM
    Neurosurgery; 2001 Aug; 49(2):380-9; discussion 390. PubMed ID: 11504114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of nonpeptide integrin antagonists.
    Nicolaou KC; Trujillo JI; Jandeleit B; Chibale K; Rosenfeld M; Diefenbach B; Cheresh DA; Goodman SL
    Bioorg Med Chem; 1998 Aug; 6(8):1185-208. PubMed ID: 9784861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
    Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular determinants of glioma cell migration and invasion.
    Wild-Bode C; Weller M; Wick W
    J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo effects of a cyclic peptide with affinity for the alpha(nu)beta3 integrin in human melanoma cells.
    Allman R; Cowburn P; Mason M
    Eur J Cancer; 2000 Feb; 36(3):410-22. PubMed ID: 10708944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
    Tarui T; Miles LA; Takada Y
    J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.